Research graph
References from Associations Between Antiparietal Cell Antibody Values and Atrophy in a South and Southeast Asian General Population. Local targets link to admitted publications; unresolved targets remain external evidence.
Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in Northern Sweden between 1990 and 2009
10.1016/j.cgh.2015.04.001 · 2015 · External reference
Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan
10.1007/s00535-022-01954-9 · 2023 · External reference
Prevalence of autoimmune gastritis in individuals undergoing medical checkups in Japan
10.2169/internalmedicine.2292-18 · 2019 · External reference
Kyoto global consensus report on Helicobacter pylori gastritis
10.1136/gutjnl-2015-309252 · 2015 · External reference
Helicobacter pylori infection and the development of gastric cancer
10.1056/nejmoa001999 · 2001 · External reference
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
10.1038/35006081 · 2000 · External reference
Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany
10.1158/1055-9965.epi-12-1343 · 2013 · External reference
Factors associated with parietal cell autoantibodies in the general population
10.1016/j.imlet.2012.06.004 · 2012 · External reference
Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases
10.1016/j.autrev.2010.08.006 · 2010 · External reference
Decreased anti-parietal cell antibody titer in the advanced phase of autoimmune gastritis
10.1080/00365521.2021.1994642 · 2022 · External reference
Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency
10.1038/ajg.2009.231 · 2009 · External reference
Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence
10.1111/j.1523-5378.2012.00967.x · 2012 · External reference
Topography of chronic active gastritis in Helicobacter pylori-positive Asian populations: age-, gender-, and endoscopic diagnosis-matched study
10.1007/s00535-003-1329-y · 2004 · External reference
Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study
2007 · External reference
Gastric mucosa in Mongolian and Japanese patients with gastric cancer and Helicobacter pylori infection
10.3748/wjg.v21.i27.8408 · 2015 · External reference
Helicobacter pylori infection, mucosal atrophy and intestinal metaplasia in Asian populations: a comparative study in age-, gender- and endoscopic diagnosis-matched subjects
10.1046/j.1523-5378.2003.00121.x · 2003 · External reference
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
10.1097/00000478-199610000-00001 · 1996 · External reference
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
10.1007/s00535-019-01639-w · 2020 · External reference
Helicobacter pylori in North and South America before Columbus
10.1016/s0014-5793(02)02617-0 · 2002 · External reference
Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer
10.1111/j.1440-1746.2006.04442.x · 2007 · External reference
Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - “ABC method
10.2183/pjab.87.405 · 2011 · External reference
Potential peptic activity of pepsinogen of human gastroduodenal mucosa determined by fluorescent microassay method using succinyl albumin
10.1016/0009-8981(82)90243-1 · 1982 · External reference
Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer
10.1111/j.1349-7006.1993.tb02805.x · 1993 · External reference
Significance of serum Pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis
10.1371/journal.pone.0142080 · 2015 · External reference
Role of Helicobacter pylori cagA EPIYA motif and vacA genotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis
10.1186/1471-2334-12-223 · 2012 · External reference
Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry
10.1016/j.molmed.2004.06.001 · 2004 · External reference
Update on serum biomarkers in autoimmune atrophic gastritis
10.1093/clinchem/hvad082 · 2023 · External reference
Comparison of different immunoassays for the detection of antibodies against Intrinsic Factor and Parietal Cells
10.1016/j.jim.2020.112867 · 2020 · External reference
Luminescent immunoprecipitation system (LIPS) for detection of autoantibodies against ATP4A and ATP4B subunits of gastric proton pump H+,K+-ATPase in atrophic body gastritis patients
10.1038/ctg.2016.71 · 2017 · External reference
Association of Helicobacter pylori and gastric autoimmunity: a population-based study
10.1111/j.1574-695x.1995.tb00079.x · 1995 · External reference
Anti-gastric parietal cell antibodies for autoimmune gastritis screening in juvenile autoimmune thyroid disease
10.1007/s40618-019-01081-y · 2020 · External reference
Autoimmune atrophic gastritis--pathogenesis, pathology and management
10.1038/nrgastro.2013.101 · 2013 · External reference
Autoimmune gastritis: pathologist’s viewpoint
10.3748/wjg.v21.i42.12179 · 2015 · External reference
